Following reports that certain antihyperglycemic agents increased CV events [16, 17], the FDA issued new guidelines in 2008 requiring that drug developers perform comprehensive assessment of CV safety on any new diabetes drug to ensure that these therapies do not increase the risk of CV events
Protecting Muscle & Bone Mass About 20%, up to 40% (Spreckley 2026) of total weight lost can come from muscle tissuesomething especially concerning for women in perimenopause or menopause, who are already losing lean mass with age
Evidence from Patient Reports and Side Effects Data from patient-reported outcomes in various semaglutide trials have shown a mixed picture regarding acid reflux
This article hasn't independently audited each one
Conversely, most AD cases are considered to be late onset AD (LOAD) that mostly debuts after 65 years
Note: for treatments that require lab work, such as testosterone-related care, lab panels are billed separately